Status:
COMPLETED
The Efficacy of Three Months-prednisolone Therapy for Chronic Eosinophilic Pneumonia
Lead Sponsor:
Hamamatsu University
Conditions:
Eosinophilic Pneumonia
Chronic Disease
Eligibility:
All Genders
16-80 years
Phase:
PHASE4
Brief Summary
A comparison of 3 months-prednisolone administration with 6 months-prednisolone therapy in the treatment of chronic eosinophilic pneumonia. Three months-prednisolone administration may be as effective...
Eligibility Criteria
Inclusion
- Biopsy-proven chronic eosinophilic pneumonia
Exclusion
- Patients who received oral glucocorticosteroid (more than 10 mg)
- Immunosuppressive drug
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00632554
Start Date
June 1 2008
End Date
March 1 2010
Last Update
September 19 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hamamatsu University School of Medicine
Hamamatsu, Japan